Altimmune Q1 2026 Earnings Narrower Loss Surprises Amid Ongoing Clinical Focus SSC Technologies Q1 2026 Earnings EPS Slightly Beats Estimates Amid Operational Resilience CHTR Q1 2026 Earnings EPS Misses Estimates as Broadband Subscriber Trends Pressure Results Euronet Worldwide EEFT Q1 2026 Earnings EPS Beat Drives Nuanced Outlook Amid Broader Market Headwinds BCHT Q1 2026 Earnings WiderthanExpected Loss as Revenue Remains Unreported Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status